Children: Centers for Disease Control and Prevention classification, 1994
The Centers for Disease Control and Prevention (CDC) classify HIV-infected children either according to their immunological status (using CD4 cell counts and percentages) or their clinical status (based on physical health and symptoms)[1].
Immunological categories
Very young children normally have much higher CD4 counts than adults. The classification system for HIV-positive based on their CD4 levels therefore takes account of the child's age.
Children aged less than twelve months
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 1499 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 740 and 1499 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 750 cells/mm3 or CD4 percentage below 15%.
Children aged one to five years
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 999 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 500 and 999 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 500 cells/mm3 or CD4 percentage below 15%.
Children aged six to twelve years
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 500 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 200 and 499 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 200 cells/mm3 or CD4 percentage below 15%.
Clinical categories
Children are assigned to:
- Category N (not symptomatic): no signs or symptoms considered to be the result of HIV infection or only one of the conditions listed in Category A.
- Category A (mildly symptomatic): two or more of the conditions listed below but none of the conditions listed in Categories B and C.
- Lymphadenopathy larger than 0.5 cm at more than two sites.
- Hepatomegaly.
- Splenomegaly.
- Dermatitis.
- Parotitis.
- Recurrent or persistent upper respiratory infection, sinusitis or otitis media.
- Category B (moderately symptomatic): symptomatic conditions other than those listed for Category A or C that are attributed to HIV infection. Examples of conditions in clinical Category B include but are not limited to:
- Anaemia, neutropenia or thrombocytopenia persisting for longer than 30 days.
- Bacterial meningitis, pneumonia, or sepsis.
- Persistent oropharyngeal candidiasis in children less than six months of age.
- Cardiomyopathy.
- Cytomegalovirus infection, with onset before one month of age.
- Diarrhoea, recurrent or chronic.
- Hepatitis.
- Recurrent herpes simplex virus stomatitis.
- Herpes simplex virus bronchitis, pneumonitis, or oesophagitis with onset before one month of age.
- Herpes zoster involving at least two distinct episodes or more than one skin area.
- Leiomyosarcoma.
- Lymphoid interstitial pneumonia or pulmonary lymphoid hyperplasia complex.
- Nephropathy.
- Nocardiosis.
- Persistent fever lasting longer than one month.
- Toxoplasmosis, onset before one month of age.
- Disseminated varicella.
- Category C (severely symptomatic): any condition listed in the 1987 surveillance case definition for AIDS, with the exception of lymphoid interstitial pneumonia.
latest aidsmap news
- Fluconazole shown to be more effective against cryptococcal meningitis at higher dose
- Promising early results for large-scale study of community-level HIV prevention initiative
- GNP+ launches website documenting global HIV exposure / transmission laws and prosecutions
- Widespread resistance to antiretrovirals among children in the Central African Republic
- Children starting HIV treatment in sub-Saharan Africa have a low risk of death
- Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole
- Rare abacavir liver side-effects reported
- Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
- Traditional healers could play key role in ART rollout
- HIV testing for mothers and children must expand, UN report shows
